Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
COM
Direxion Auspice Broad Commodity Strategy ETF
$29.41
+0.2%
$28.53
$27.56
$31.62
$261.75M0.1946,850 shs82,063 shs
PREV
PreveCeutical Medical
$0.00
$0.00
$0.00
N/AN/AN/A694,224 shs
TNGN
Tengion
$0.00
$0.00
$0.00
N/AN/A6,051 shs10,000 shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
COM
Direxion Auspice Broad Commodity Strategy ETF
+0.41%+0.17%+4.60%+5.50%-5.99%
PREV
PreveCeutical Medical
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
COM
Direxion Auspice Broad Commodity Strategy ETF
N/AN/AN/AN/AN/AN/AN/AN/A
PREV
PreveCeutical Medical
N/AN/AN/AN/AN/AN/AN/AN/A
TNGN
Tengion
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
COM
Direxion Auspice Broad Commodity Strategy ETF
0.00
N/AN/AN/A
PREV
PreveCeutical Medical
N/AN/AN/AN/A
TNGN
Tengion
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
COM
Direxion Auspice Broad Commodity Strategy ETF
N/AN/AN/AN/AN/AN/A
PREV
PreveCeutical Medical
N/AN/AN/AN/AN/AN/A
TNGN
Tengion
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
COM
Direxion Auspice Broad Commodity Strategy ETF
N/AN/A0.00N/AN/AN/AN/AN/A
PREV
PreveCeutical Medical
N/AN/A0.00N/AN/AN/AN/AN/AN/A
TNGN
Tengion
N/AN/A0.00N/AN/AN/AN/AN/AN/A

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
COM
Direxion Auspice Broad Commodity Strategy ETF
$2.538.59%N/AN/AN/A
PREV
PreveCeutical Medical
N/AN/AN/AN/AN/A
TNGN
Tengion
N/AN/AN/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
COM
Direxion Auspice Broad Commodity Strategy ETF
N/A
PREV
PreveCeutical Medical
N/A
TNGN
Tengion
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
COM
Direxion Auspice Broad Commodity Strategy ETF
N/A8.90 millionN/ANot Optionable
PREV
PreveCeutical Medical
N/AN/AN/ANot Optionable
TNGN
Tengion
147,000N/AN/ANot Optionable

BPH, PREV, TNGN, and COM Headlines

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Top Headlines

All Headlines

Company Descriptions

Direxion Auspice Broad Commodity Strategy ETF

NYSEARCA:COM
The Direxion Auspice Broad Commodity Strategy ETF (COM) is an exchange-traded fund that is based on the Auspice Broad Commodity index. The fund tracks a broad-market index consisting of 12 commodity futures contracts, weighted by historical volatility, which can toggle to cash based on momentum. The fund will also hold short-term fixed income securities as collateral. COM was launched on Mar 30, 2017 and is managed by Direxion.

PreveCeutical Medical

CNSX:PREV
PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; BSV Peptide Program for targeting cancer progression; Non-Addictive Analgesic for pain management; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.

Tengion

OTCMKTS:TNGN
Tengion, Inc. is a medicine company, focuses on discovering, developing, manufacturing and commercializing of neo-organs and products. The company was founded by Steven Nichtberger and David I. Scheer on July 10, 2003 and is headquartered in Winston-Salem, NC.